Review
. 2002 May;6(4).
doi: 10.1023/a:1014778713034.

Prognostic factors in breast cancer: current and new predictors of metastasis

D F Hayes 1 C Isaacs  V Stearns  
Affiliations
  • PMID: 12013528
  •     88 References
  •     76 citations

Abstract

Decisions regarding the use of adjuvant therapy for breast cancer are strongly influenced by the risk of disease recurrence and death. These risks are now determined by examining the currently recognized breast cancer prognostic factors, including clinical stage, axillary nodal status, tumor size and grade, hormone receptor status, and presence of lymphovascular involvement. Newer factors are being evaluated in an attempt to more precisely define disease-related prognosis. This paper provides an overview of issues that need to be considered when analyzing studies of prognostic factors as well as a review of the currently recognized and the newer candidate prognostic factors.

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.
A L Schechter, D F Stern, +4 authors, R A Weinberg.
Nature, 1984 Dec 06; 312(5994). PMID: 6095109
Highly Cited.
The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.
R W Stephens, N Brünner, F Jänicke, M Schmitt.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066075
Review.
Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study.
K W Gilchrist, L Kalish, +7 authors, J A Roth.
Breast Cancer Res Treat, 1985 Jan 01; 5(1). PMID: 3978246
Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869.
Anthony J Guidi, Donald A Berry, +6 authors, Daniel F Hayes.
J Clin Oncol, 2002 Feb 01; 20(3). PMID: 11821455
Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
Y Utada, M Emi, +6 authors, Y Nakamura.
Clin Cancer Res, 2000 Aug 24; 6(8). PMID: 10955803
Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
R Seshadri, C S Lee, +3 authors, R L Sutherland.
Clin Cancer Res, 1996 Jul 01; 2(7). PMID: 9816285
Sentinel lymphadenectomy in breast cancer.
A E Giuliano, R C Jones, M Brennan, R Statman.
J Clin Oncol, 1997 Jun 01; 15(6). PMID: 9196149
Highly Cited.
Osteopontin expression in a group of lymph node negative breast cancer patients.
A B Tuck, F P O'Malley, +6 authors, A F Chambers.
Int J Cancer, 1998 Oct 07; 79(5). PMID: 9761120
Prognostic variables in node-negative and node-positive breast cancer.
G Gasparini.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066090
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.
P P Rosen, S Groshen, D W Kinne, L Norton.
J Clin Oncol, 1993 Nov 01; 11(11). PMID: 8229123
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.
G Contesso, H Mouriesse, +3 authors, J Rouesse.
J Clin Oncol, 1987 Sep 01; 5(9). PMID: 3625256
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
M F Press, L Bernstein, +12 authors, K J Flom.
J Clin Oncol, 1997 Aug 01; 15(8). PMID: 9256133
Highly Cited.
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
P L Fitzgibbons, D L Page, +11 authors, S J Schnitt.
Arch Pathol Lab Med, 2000 Jul 11; 124(7). PMID: 10888772
Highly Cited. Review.
Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
A D Thor, S Liu, D H Moore, S M Edgerton.
J Clin Oncol, 1999 Mar 18; 17(2). PMID: 10080587
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.
D F Hayes, R C Bast, +10 authors, R J Winn.
J Natl Cancer Inst, 1996 Oct 16; 88(20). PMID: 8841020
Highly Cited. Review.
High levels of TIMP-2 correlate with adverse prognosis in breast cancer.
A Remacle, K McCarthy, +5 authors, M J Duffy.
Int J Cancer, 2001 Feb 07; 89(2). PMID: 10756061
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
R Heimann, F Lan, R McBride, S Hellman.
Cancer Res, 2000 Feb 10; 60(2). PMID: 10667580
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
R Hui, R D Macmillan, +5 authors, R L Sutherland.
Clin Cancer Res, 2000 Jul 29; 6(7). PMID: 10914724
Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.
I Funke, W Schraut.
J Clin Oncol, 1998 Feb 20; 16(2). PMID: 9469341
Cyclin D1 and prognosis in human breast cancer.
C Gillett, P Smith, +4 authors, D Barnes.
Int J Cancer, 1996 Apr 22; 69(2). PMID: 8608989
Highly Cited.
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer.
H Yamauchi, V Stearns, D F Hayes.
J Clin Oncol, 2001 Apr 17; 19(8). PMID: 11304787
Review.
Breast cancer prognostic factors: evaluation guidelines.
W L McGuire.
J Natl Cancer Inst, 1991 Feb 06; 83(3). PMID: 1988696
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
I J Diel, M Kaufmann, +5 authors, G Bastert.
J Natl Cancer Inst, 1996 Nov 20; 88(22). PMID: 8931609
Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients.
G Gasparini, F Pozza, A L Harris.
J Natl Cancer Inst, 1993 Aug 04; 85(15). PMID: 8331681
Review.
New prognostic factors for breast cancer recurrence.
C Isaacs, V Stearns, D F Hayes.
Semin Oncol, 2001 Mar 20; 28(1). PMID: 11254867
Review.
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, +3 authors, W L McGuire.
Science, 1987 Jan 09; 235(4785). PMID: 3798106
Highly Cited.
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
S Krajewski, A D Thor, +3 authors, J C Reed.
Clin Cancer Res, 1997 Feb 01; 3(2). PMID: 9815673
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer.
G Gasparini.
Crit Rev Oncol Hematol, 2001 Feb 13; 37(2). PMID: 11166583
Review.
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet, 1998 May 30; 351(9114). PMID: 9605801
Highly Cited.
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
J A Foekens, H A Peters, +9 authors, J G Klijn.
Cancer Res, 2000 Feb 17; 60(3). PMID: 10676647
Highly Cited.
Immunohistologic evaluation of invasion-associated proteases in breast carcinoma.
D W Visscher, F Sarkar, +4 authors, J D Crissman.
Mod Pathol, 1993 May 01; 6(3). PMID: 8346178
Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up.
G Gebauer, T Fehm, +3 authors, W Jäger.
J Clin Oncol, 2001 Aug 16; 19(16). PMID: 11504748
Status of breast cancer prognostication based on histopathologic data.
J F Simpson, D L Page.
Am J Clin Pathol, 1994 Oct 01; 102(4 Suppl 1). PMID: 7942611
Review.
I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.
W S Halsted.
Ann Surg, 1894 Nov 01; 20(5). PMID: 17860107    Free PMC article.
Highly Cited.
Prognostic factors and treatment decisions in axillary-node-negative breast cancer.
W L McGuire, G M Clark.
N Engl J Med, 1992 Jun 25; 326(26). PMID: 1594018
Review.
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun, K Pantel, +9 authors, G Schlimok.
N Engl J Med, 2000 Feb 24; 342(8). PMID: 10684910
Highly Cited.
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
C A Quiet, D J Ferguson, R R Weichselbaum, S Hellman.
J Clin Oncol, 1995 May 01; 13(5). PMID: 7738620
Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?
D F Hayes, B Trock, A L Harris.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066089
Review.
Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
R W Brown, C D Allred, +2 authors, S G Hilsenbeck.
Clin Cancer Res, 1996 Mar 01; 2(3). PMID: 9816207
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C W Elston, I O Ellis.
Histopathology, 1991 Nov 01; 19(5). PMID: 1757079
Highly Cited.
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
P P Rosen, S Groshen, +2 authors, S Hellman.
J Clin Oncol, 1989 Sep 01; 7(9). PMID: 2549203
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
C Lindley, S Vasa, W T Sawyer, E P Winer.
J Clin Oncol, 1998 Apr 29; 16(4). PMID: 9552041
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
R Peto, J Boreham, +2 authors, V Beral.
Lancet, 2000 Jun 01; 355(9217). PMID: 10832853
Highly Cited.
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.
T Ueno, M Toi, +2 authors, T Tominaga.
Br J Cancer, 2000 Jul 20; 83(2). PMID: 10901365    Free PMC article.
What is the evidence that tumors are angiogenesis dependent?
J Folkman.
J Natl Cancer Inst, 1990 Jan 03; 82(1). PMID: 1688381
Highly Cited.
Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.
P M Ravdin, I A Siminoff, J A Harvey.
J Clin Oncol, 1998 Feb 20; 16(2). PMID: 9469335
Individual characterisation of the metastatic capacity of human breast carcinoma.
R Heimann, S Hellman.
Eur J Cancer, 2000 Aug 26; 36(13 Spec No). PMID: 10959049
Review.
Bcl-2 and the regulation of programmed cell death.
J C Reed.
J Cell Biol, 1994 Jan 01; 124(1-2). PMID: 8294493    Free PMC article.
Highly Cited. Review.
DNA methylation in breast cancer.
X Yang, L Yan, N E Davidson.
Endocr Relat Cancer, 2001 Jul 12; 8(2). PMID: 11446343
Review.
Prognostic and predictive value of thymidine labelling index in breast cancer.
D Amadori, R Silvestrini.
Breast Cancer Res Treat, 1999 Mar 06; 51(3). PMID: 10068084
Review.
Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
S Rajagopal, P J Goodman, I F Tannock.
J Clin Oncol, 1994 Jun 01; 12(6). PMID: 8201392
American Joint Committee on Cancer prognostic factors consensus conference.
J W Yarbro, D L Page, +2 authors, G P Murphy.
Cancer, 1999 Dec 11; 86(11). PMID: 10590388
Review.
Statistical aspects of prognostic factor studies in oncology.
R Simon, D G Altman.
Br J Cancer, 1994 Jun 01; 69(6). PMID: 8198989    Free PMC article.
Highly Cited. Review.
Cyclin D1 in breast cancer.
D M Barnes, C E Gillett.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066068
Review.
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet, 1998 Sep 30; 352(9132). PMID: 9752815
Highly Cited.
Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients.
Kalliopi P. Siziopikou, Stuart J. Schnitt, James L. Connolly, Daniel F. Hayes.
Breast J, 2001 May 12; 5(4). PMID: 11348291
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.
L W Dalton, S E Pinder, +4 authors, R W Blamey.
Mod Pathol, 2000 Jul 27; 13(7). PMID: 10912931
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
R C Bast, P Ravdin, +8 authors, American Society of Clinical Oncology Tumor Markers Expert Panel.
J Clin Oncol, 2001 Mar 17; 19(6). PMID: 11251019
Highly Cited.
Time-dependence of hazard ratios for prognostic factors in primary breast cancer.
S G Hilsenbeck, P M Ravdin, +3 authors, G M Clark.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066085
The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
R Yoshida, N Kimura, Y Harada, N Ohuchi.
Int J Oncol, 2001 Feb 17; 18(3). PMID: 11179480
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
B Fisher, C Redmond, E R Fisher, R Caplan.
J Clin Oncol, 1988 Jul 01; 6(7). PMID: 2856862
Highly Cited.
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.
N Weidner, J Folkman, +5 authors, G Gasparini.
J Natl Cancer Inst, 1992 Dec 16; 84(24). PMID: 1281237
Highly Cited.
Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.
G Ferrandina, G Scambia, +3 authors, A Messori.
Br J Cancer, 1997 Jan 01; 76(5). PMID: 9303368    Free PMC article.
The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.
R Heimann, D J Ferguson, S Hellman.
Cancer Res, 1998 Jul 14; 58(13). PMID: 9661889
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.
A M Neville, R Bettelheim, +7 authors, K N Price.
J Clin Oncol, 1992 May 01; 10(5). PMID: 1569442
Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
O I Olopade, M O Adeyanju, +4 authors, W M Recant.
Cancer J Sci Am, 1997 Jul 01; 3(4). PMID: 9263629
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.
C L Carter, C Allen, D E Henson.
Cancer, 1989 Jan 01; 63(1). PMID: 2910416
Highly Cited.
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
G Gasparini, M Toi, +10 authors, T Tominaga.
J Natl Cancer Inst, 1997 Jan 15; 89(2). PMID: 8998183
Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet, 1996 Nov 02; 348(9036). PMID: 8898035
S-phase fraction and breast cancer--a decade of experience.
C R Wenger, G M Clark.
Breast Cancer Res Treat, 1999 Mar 06; 51(3). PMID: 10068083
Review.
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet, 2000 Jun 01; 355(9217). PMID: 10832826
Highly Cited.
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.
H J BLOOM, W W RICHARDSON.
Br J Cancer, 1957 Sep 01; 11(3). PMID: 13499785    Free PMC article.
Highly Cited.
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
U Eppenberger, W Kueng, +10 authors, S Eppenberger-Castori.
J Clin Oncol, 1998 Sep 17; 16(9). PMID: 9738585
Cathepsin D and breast cancer.
B R Westley, F E May.
Eur J Cancer, 1996 Jan 01; 32A(1). PMID: 8695224
Review.
Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.
M Emi, M Yoshimoto, +18 authors, Y Nakamura.
Genes Chromosomes Cancer, 1999 Sep 01; 26(2). PMID: 10469451
1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.
J Clin Oncol, 1998 Feb 20; 16(2). PMID: 9469371
Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients.
P M Ravdin, C A de Moor, +3 authors, G M Clark.
Cancer Lett, 1997 Jun 24; 116(2). PMID: 9215861
The sentinel node in breast cancer--a multicenter validation study.
D Krag, D Weaver, +9 authors, P Beitsch.
N Engl J Med, 1998 Oct 01; 339(14). PMID: 9753708
Highly Cited.
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
H Yu, M A Levesque, G M Clark, E P Diamandis.
Br J Cancer, 1999 Oct 03; 81(3). PMID: 10507775    Free PMC article.
Methodological challenges in the evaluation of prognostic factors in breast cancer.
D G Altman, G H Lyman.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066088
Review.
Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
C MacGeoch, G Turner, +3 authors, N K Spurr.
J Med Genet, 1995 Mar 01; 32(3). PMID: 7783166    Free PMC article.
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.
P M Ravdin, L A Siminoff, +4 authors, H L Parker.
J Clin Oncol, 2001 Feb 22; 19(4). PMID: 11181660
Highly Cited.
How to use prognostic factors in axillary node-negative breast cancer patients.
W L McGuire, A K Tandon, +2 authors, G M Clark.
J Natl Cancer Inst, 1990 Jun 20; 82(12). PMID: 2189998
Review.
Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.
S Krajewski, C Blomqvist, +5 authors, J C Reed.
Cancer Res, 1995 Oct 01; 55(19). PMID: 7671262
Highly Cited.
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis.
P D Pharoah, N E Day, C Caldas.
Br J Cancer, 1999 Sep 02; 80(12). PMID: 10471047    Free PMC article.
When and to what end do pathologists agree?
D L Page, W D Dupont, R A Jensen, J F Simpson.
J Natl Cancer Inst, 1998 Feb 05; 90(2). PMID: 9450563
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
J Clin Oncol, 1996 Oct 01; 14(10). PMID: 8874347
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
F Jänicke, A Prechtl, +8 authors, German N0 Study Group.
J Natl Cancer Inst, 2001 Jun 21; 93(12). PMID: 11416112
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Celina G Kleer, Qi Cao, +12 authors, Arul M Chinnaiyan.
Proc Natl Acad Sci U S A, 2003 Sep 23; 100(20). PMID: 14500907    Free PMC article.
Highly Cited.
p27 deregulation in breast cancer: prognostic significance and implications for therapy.
A Alkarain, R Jordan, J Slingerland.
J Mammary Gland Biol Neoplasia, 2004 Apr 15; 9(1). PMID: 15082919
Review.
Biological characterisation of breast cancer by means of PET.
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske.
Eur J Nucl Med Mol Imaging, 2004 May 06; 31 Suppl 1. PMID: 15127240
Review.
Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer.
Matthew J LeBaron, Jianwu Xie, Hallgeir Rui.
Mol Cancer, 2005 Feb 03; 4(1). PMID: 15686596    Free PMC article.
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
M Burkhardt, E Mayordomo, +8 authors, G Kristiansen.
J Clin Pathol, 2006 Feb 18; 59(4). PMID: 16484444    Free PMC article.
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.
G Des Guetz, B Uzzan, +5 authors, G-Y Perret.
Br J Cancer, 2006 Jun 15; 94(12). PMID: 16773076    Free PMC article.
Highly Cited.
Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer.
Marcia V Fournier, Katherine J Martin, +4 authors, Mina J Bissell.
Cancer Res, 2006 Jul 20; 66(14). PMID: 16849555    Free PMC article.
Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
Mónica Muñoz-de-Toro, Milena Durando, +4 authors, Enrique H Luque.
Breast Cancer Res, 2006 Jul 25; 8(4). PMID: 16859517    Free PMC article.
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.
Y Nieto, J Woods, +4 authors, S Nawaz.
Br J Cancer, 2007 Jul 05; 97(3). PMID: 17609662    Free PMC article.
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.
Douglas T Ross, Chung-Yeul Kim, +7 authors, Norman Wolmark.
Clin Cancer Res, 2008 Oct 18; 14(20). PMID: 18927301    Free PMC article.
Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.
M E Gonzalez, X Li, +6 authors, C G Kleer.
Oncogene, 2008 Dec 17; 28(6). PMID: 19079346    Free PMC article.
p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis.
Xiaoxiang Guan, Yucai Wang, +4 authors, Macus Tien Kuo.
J Cell Mol Med, 2009 Mar 21; 14(4). PMID: 19298520    Free PMC article.
Systematic Review.
Tissue inhibitor of metalloproteinase-4 is elevated in early-stage breast cancers with accelerated progression and poor clinical course.
Michaelann Liss, Nandhini Sreedhar, +4 authors, U Margaretha Wallon.
Am J Pathol, 2009 Aug 25; 175(3). PMID: 19700750    Free PMC article.
A population-based gene signature is predictive of breast cancer survival and chemoresponse.
Shruti Rathnagiriswaran, Ying-Wooi Wan, +3 authors, Nancy L Guo.
Int J Oncol, 2010 Feb 04; 36(3). PMID: 20126981    Free PMC article.
CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.
Feng Jing, Wang Yuping, +4 authors, Hu Lihua.
Tumour Biol, 2010 May 22; 31(4). PMID: 20490964
Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis.
Ying Wu, Xiaonan Fu, +7 authors, Yulan Zhao.
J Cancer Res Clin Oncol, 2010 Sep 30; 137(5). PMID: 20878529
Systematic Review.
Positively biased appraisals in everyday life: when do they benefit mental health and when do they harm it?
Erin M O'Mara, James K McNulty, Benjamin R Karney.
J Pers Soc Psychol, 2011 Apr 20; 101(3). PMID: 21500926    Free PMC article.
Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Daxun Piao, Tao Jiang, +3 authors, Anlong Zhu.
Mol Biol Rep, 2011 Jun 15; 39(1). PMID: 21670959
Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.
Jing Chen, Tao Li, +6 authors, Xiufeng Pang.
J Cancer Res Clin Oncol, 2011 Sep 16; 137(12). PMID: 21918901
Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer.
Rosane Vianna-Jorge, Juliana Simões Festa-Vasconcellos, Sheyla Maria Torres Goulart-Citrangulo, Marcelo Sobral Leite.
Front Genet, 2013 Jan 25; 3. PMID: 23346096    Free PMC article.
EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.
Heather M Moore, Maria E Gonzalez, +3 authors, Celina G Kleer.
Breast Cancer Res Treat, 2013 Mar 30; 138(3). PMID: 23539298    Free PMC article.
Biofunctional characteristics of in situ and invasive breast carcinoma.
Sara Bravaccini, Anna Maria Granato, +11 authors, Dino Amadori.
Cell Oncol (Dordr), 2013 Jun 29; 36(4). PMID: 23807750
Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis.
Chanhoo Jeon, Myong Kim, +2 authors, Ja Hyeon Ku.
PLoS One, 2013 Nov 10; 8(10). PMID: 24204662    Free PMC article.
Systematic Review.
Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis.
Xiaochun Xia, Baixia Yang, +4 authors, Jing Cai.
PLoS One, 2013 Nov 23; 8(11). PMID: 24265822    Free PMC article.
The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer.
Zahra Ma Mohammed, Donald C McMillan, +4 authors, James J Going.
BMC Clin Pathol, 2013 Nov 28; 13(1). PMID: 24274633    Free PMC article.
Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies.
Jie Yang, Jia-yi Zhang, +3 authors, Chang-jun Yin.
PLoS One, 2014 Jan 30; 9(1). PMID: 24475314    Free PMC article.
Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Zhu-Qing Liu, Li Chu, +4 authors, Qing Xu.
Asian J Androl, 2014 Mar 05; 16(3). PMID: 24589465    Free PMC article.
Systematic Review.
Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis.
Minmin Li, Xuelei Ma, +4 authors, Yuquan Wei.
Dis Markers, 2014 Mar 05; 2014. PMID: 24591754    Free PMC article.
Systematic Review.
Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis.
Jing Chen, Tao Li, +4 authors, Zhenghao Huo.
PLoS One, 2014 Mar 22; 9(3). PMID: 24647137    Free PMC article.
Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis.
Yang Xia, Yi Zhu, Xiaoying Zhou, Yijiang Chen.
Tumour Biol, 2014 Apr 24; 35(6). PMID: 24756756
Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.
Adam M Brufsky.
Am J Clin Oncol, 2014 May 24; 37(4). PMID: 24853663    Free PMC article.
Systematic Review.
Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.
Claudia Cava, Gloria Bertoli, +5 authors, Isabella Castiglioni.
PLoS One, 2014 May 29; 9(5). PMID: 24866763    Free PMC article.
Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
Hong Wang, Qiongwen Zhang, +7 authors, Huashan Shi.
Int J Clin Exp Pathol, 2014 Aug 15; 7(7). PMID: 25120764    Free PMC article.
P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Hana Jin, So Young Eun, +4 authors, Hye Jung Kim.
Breast Cancer Res, 2014 Aug 27; 16(5). PMID: 25156554    Free PMC article.
P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment.
Young Nak Joo, Hana Jin, +3 authors, Hye Jung Kim.
Oncotarget, 2014 Sep 23; 5(19). PMID: 25238333    Free PMC article.
New biomarkers to predict the evolution of in situ breast cancers.
S Bravaccini, M M Tumedei, +11 authors, R Silvestrini.
Biomed Res Int, 2014 Sep 23; 2014. PMID: 25243117    Free PMC article.
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
Fang Tan, Marina Mosunjac, +5 authors, Solomon F Ofori-Acquah.
BMC Cancer, 2014 Sep 27; 14. PMID: 25255861    Free PMC article.
Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Fei Pan, Hui Mao, +2 authors, Peiliang Geng.
Int J Clin Exp Pathol, 2014 Oct 23; 7(9). PMID: 25337203    Free PMC article.
Review.
Individualized Survival and Treatment Response Predictions in Breast Cancer Patients: Involvements of Phospho-EGFR and Phospho-Her2/neu Proteins.
Lan Guo, Jame Abraham, +3 authors, Yong Qian.
Open Clin Cancer J, 2008 May 27; 2. PMID: 25558292    Free PMC article.
MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer.
Sanaa Eissa, Marwa Matboli, Hanan H Shehata, Nada O E Essawy.
Tumour Biol, 2015 Jan 19; 36(6). PMID: 25596707
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis.
Ying Huang, Ji-Feng Feng, Jin-Shi Liu, Qi-Xun Chen.
Ther Clin Risk Manag, 2015 Feb 06; 11. PMID: 25653533    Free PMC article.
Review.
Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.
Yanyan Wang, Yujie Zhang, +2 authors, Suzhan Zhang.
PLoS One, 2015 Feb 24; 10(2). PMID: 25706383    Free PMC article.
Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis.
Ke-Cheng Zhang, Hong-Qing Xi, +4 authors, Lin Chen.
Int J Clin Exp Med, 2015 May 02; 8(2). PMID: 25932122    Free PMC article.
Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis.
Yanli Zhang, Dong Zhao, +5 authors, Jing Sun.
World J Surg Oncol, 2015 Jun 26; 13. PMID: 26108802    Free PMC article.
Systematic Review.
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Gloria Bertoli, Claudia Cava, Isabella Castiglioni.
Theranostics, 2015 Jul 23; 5(10). PMID: 26199650    Free PMC article.
Highly Cited. Review.
Prognostic role of microRNA-210 in various carcinomas: a meta-analysis.
Xuejiao Xie, Wenhong Wu, +5 authors, Shikang Li.
Int J Clin Exp Med, 2015 Dec 03; 8(9). PMID: 26629015    Free PMC article.
Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.
Jia-Ming Liu, Si-Hang Cheng, +3 authors, Xue-Lei Ma.
Int J Clin Exp Med, 2016 Feb 18; 8(11). PMID: 26884999    Free PMC article.
Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis.
Geng-yuan Hu, Feng Tao, Wei Wang, Ke-wei Ji.
World J Surg Oncol, 2016 Mar 13; 14. PMID: 26969625    Free PMC article.
Prognostic role of microRNA-150 in various carcinomas: a meta-analysis.
Wei Wang, Xinshuai Wang, +4 authors, Shegan Gao.
Onco Targets Ther, 2016 Apr 05; 9. PMID: 27042106    Free PMC article.
Review.
CYC1 Predicts Poor Prognosis in Patients with Breast Cancer.
Yingyan Han, Shujuan Sun, +8 authors, Peng Wu.
Dis Markers, 2016 May 31; 2016. PMID: 27239088    Free PMC article.
Prognostic significance of microRNA-200c in various types of cancer: An updated meta-analysis of 34 studies.
Jia-Yi Zhang, Ya-Min Wang, +3 authors, Ning-Hong Song.
Mol Clin Oncol, 2016 Jun 11; 4(6). PMID: 27284426    Free PMC article.
Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.
Hyun Kyung Kong, Sae Jeong Park, +11 authors, Jong Hoon Park.
Oncotarget, 2016 Aug 06; 7(34). PMID: 27494879    Free PMC article.
LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Jianwen Chen, Yalei Chen, +10 authors, Xin Ma.
Oncotarget, 2016 Aug 17; 7(45). PMID: 27527868    Free PMC article.
Systematic Review.
Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
Chao Li, Jianjun Sun, +5 authors, Yimin Cui.
J Neurooncol, 2016 Oct 21; 130(1). PMID: 27531352
Review.
Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis.
Jing Zhang, Chi Shu, +3 authors, Xuelei Ma.
Medicine (Baltimore), 2016 Oct 18; 95(40). PMID: 27749596    Free PMC article.
Review.
The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
Manni Wang, Xuelei Ma, +4 authors, Jing Zhang.
Oncotarget, 2016 Nov 12; 7(49). PMID: 27833074    Free PMC article.
Review.
Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis.
Jing Zhang, Jiaming Liu, +6 authors, Xuelei Ma.
Oncotarget, 2017 Feb 09; 8(15). PMID: 28177889    Free PMC article.
Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis.
Linyan Chen, Xin Wu, +3 authors, Qingfang Li.
Medicine (Baltimore), 2017 Feb 09; 96(6). PMID: 28178131    Free PMC article.
Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis.
Xiuying Li, Jinfan Sun, Shuenqin Hu.
Wien Klin Wochenschr, 2017 Apr 02; 129(15-16). PMID: 28364168
Systematic review and meta-analysis of the utility of long non-coding RNA GAS5 as a diagnostic and prognostic cancer biomarker.
Wei Li, Na Li, Ke Shi, Qiong Chen.
Oncotarget, 2017 Oct 17; 8(39). PMID: 29029523    Free PMC article.
Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
Jing Yang, Xinli Guo, +3 authors, Panpan Lin.
Sci Rep, 2017 Dec 08; 7(1). PMID: 29215037    Free PMC article.
Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases.
Xia Yang, Da-Ni Zhong, +5 authors, Jin-Cai Zhong.
Oncotarget, 2018 Mar 02; 9(9). PMID: 29492222    Free PMC article.
Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis.
Jing Yang, Li Cheng, +4 authors, Xuelei Ma.
Medicine (Baltimore), 2018 Jul 12; 97(28). PMID: 29995790    Free PMC article.
Review.
Prognostic role of Toll-like receptors in cancer: a meta-analysis.
Qingwen Wang, Xiankai Zhang, +3 authors, Yulan Zhao.
Ther Clin Risk Manag, 2018 Aug 15; 14. PMID: 30104878    Free PMC article.
Prognostic Significance of P16INK4a Expression in Penile Squamous Cell Carcinoma: A Meta-Analysis with Trial Sequential Analysis.
Jiayi Zhang, Hengcheng Zhang, +3 authors, Ninghong Song.
Biomed Res Int, 2018 Aug 15; 2018. PMID: 30105253    Free PMC article.
Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era.
Eleftherios P Mamounas, Christy A Russell, +2 authors, Kathy S Albain.
NPJ Breast Cancer, 2018 Aug 30; 4. PMID: 30155517    Free PMC article.
Review.
Prognostic role of microvessel density in patients with glioma.
Chaofeng Fan, Jing Zhang, +6 authors, Jianguo Xu.
Medicine (Baltimore), 2019 Mar 01; 98(9). PMID: 30817605    Free PMC article.
The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy.
Chenjing Zhu, Otilia Menyhart, Balázs Győrffy, Xia He.
BMC Cancer, 2019 Nov 07; 19(1). PMID: 31690268    Free PMC article.
The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma.
Jing Yang, Xinli Guo, +3 authors, Xuelei Ma.
Front Oncol, 2020 Jan 11; 9. PMID: 31921649    Free PMC article.
Expression of cleaved caspase-3 predicts good chemotherapy response but poor survival for patients with advanced primary triple-negative breast cancer.
Xiaodan Liu, Shenyi Jiang, Xin Tian, Youhong Jiang.
Int J Clin Exp Pathol, 2018 Sep 01; 11(9). PMID: 31949833    Free PMC article.
Prognostic role of microRNA-31 in various cancers: a meta-analysis.
Shuwei Wang, Jun Hu, +3 authors, Yueming Sun.
Tumour Biol, 2014 Aug 21; 35(11). PMID: 25139099
Safety and efficacy profile of cyclin-dependent kinases 4/6 inhibitor palbociclib in cancer therapy: A meta-analysis of clinical trials.
Linghong Guo, Yuanyuan Hu, +3 authors, Xuelei Ma.
Cancer Med, 2019 Mar 22; 8(4). PMID: 30897298    Free PMC article.
The Emerging Role of MicroRNAs in Breast Cancer.
Zhiguang Yang, Zhaoyu Liu.
J Oncol, 2020 Jul 28; 2020. PMID: 32714393    Free PMC article.
Review.
Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
Yan-Ling Chen, Xiao-Lin Liu, Ling Li.
BMC Cancer, 2021 Jan 16; 21(1). PMID: 33446130    Free PMC article.
Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.
Hsing-Ju Wu, Pei-Yi Chu.
Int J Mol Sci, 2021 Jan 14; 22(2). PMID: 33435254    Free PMC article.
Review.
Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
Chunni Fan, Jianshi Du, Ning Liu.
Comput Math Methods Med, 2021 Mar 11; 2021. PMID: 33688372    Free PMC article.